[用心脏选择性β受体阻滞剂（托拉洛尔）治疗室上性心律失常]
[Therapy of supraventricular arrhythmias with a cardioselective beta-receptor blocker (tolamolol)].
作者信息
Pfisterer M, Halter J, Nager F
出版信息
Schweiz Med Wochenschr. 1976 Apr 17;106(16):549-50.
PMID:989952
Abstract
In order to evaluate the effect of a new cardioselective beta-blocker (tolamolol) on supraventricular tachyarrhythmias, 10-30 mg of tolamolol was administered on 38 occasions to 35 patients. It is concluded that tolamolol reduces ventricular rate in supraventricular tachyarrhythmias and is often effective in converting paroxysmal atrial fibrillation to sinus rhythm.
摘要
为了评估一种新型心脏选择性β受体阻滞剂（托拉洛尔）对室上性快速心律失常的疗效，对35例患者38次给予10 - 30毫克托拉洛尔。结论是托拉洛尔可降低室上性快速心律失常的心室率，且常能有效将阵发性心房颤动转为窦性心律。
Zotero 插件